Drug shortages and pricing instability on generic injectables continue to burden healthcare providers and the patients they serve. HealthTrust is pleased to announce innovative Supply Interruption Mitigation Strategies (SIMS) to create stability and improve predictability around the supply of medications deemed critical to patient care. “In a global economy, understanding the intricate supply chains of […]
*HealthTrust’s definition of “new technology” is classified as a product that, as compared to existing products:
- Offers significant technological advancements,
- Significantly improves clinical outcomes or patient care (i.e., documented reduction in procedure times, outcomes, lengths of stay, readmissions, infection rates), or
- Significantly streamlines work processes and/or the economics of facility operations (i.e., increase or decrease expenses in supply chain or resource utilization).
Demonstration of this via independent, peer-reviewed publication(s) is beneficial but not required.*
Get recent industry best-practice articles and insights from HealthTrust.